Subdural
Hematoma
Epidemiology and
Etiology:
·
Trauma
·
Manifest within 48h after injury
·
Elderly
·
Demented
·
In these conditions the brain is atrophied and therefore more
freely mobile, and the veins are stretched more
·
Infants
·
Bridging veins are thin-walled
·
Previous subdural hematoma
·
Tend to rebleed
·
Risk greatest in first few months
Common sites:
·
Bridging veins from surface of cerebral hemispheres to superior sagittal sinus
·
Lateral aspects of cerebral hemispheres
Gross features:
·
Acute
·
Freshly clotted blood along the contour of the brain surface
·
No extension into depths of sulci
·
Underlying brain is flattened
·
Subarachnoid space is often clear
·
Chronic
·
Lesion is firmly attached only to the inner surface of the dura and not at all adherent to the underlying smooth arachnoid
·
Lesion can eventually retract until there may be only a thin
layer of reactive connective tissue (“subdural membranes”)
·
Bilateral (10%)
Histologic
features:
·
Acute:
·
24h - Thin layer of fibrin between dura
and clot
·
48-72h
·
rare fibroblast at interface between dura
and clot
·
Fibrin only at arachnoid-clot interface
·
Subacute:
·
4-5d
·
RBCs begin to break down
·
2-5 cell thick layer of fibroblasts at dura-clot
interface
·
Occasional spindle cell within fibrin at arachnoid-clot
interface
·
5-10d
·
3-14 cell thick layer of fibroblasts at dura-clot
interface
·
Occasional small capillaries
·
Pigment-laden macrophages
·
Mostly fibrin with some fibroblasts at arachnoid-clot
interface
·
10-20d
·
fibroblast layer 1/3 to ˝ as thick as dura
at dural-clot interface
·
capillaries present
·
pigment-laden macrophages present
·
early fibroblastic membrane at arachnoid-clot
interface
·
Chronic:
·
3-4 weeks
·
Membrane equal to dura in thickness at dural-clot interface
·
Pigment-laden macrophages present
·
Fibroblastic membrane about ˝ as thick as dura
at arachnoid-clot interface
·
Occasional pigment-laden macrophages
·
5 weeks:
·
Large capillaries present
·
Membrane well-formed at both dural-clot
and arachnoid clot interface
·
1-3 months:
·
Large (giant) capillaries maybe
·
Secondary hemorrhage (re-bleed)
·
Hyalinization of membrane at both dural-clot
and arachnoid-clot interface
Immunophenotype:
Marker: |
Sensitivity: |
Specificity: |
|
|
|
Molecular features:
·
Other features:
·
Treatment is to remove the organized blood and associated
organizing tissue (to prevent rebleed)
References:
·
Kumar V, Fausto N, Abbas
A. Robbins & Cotran Pathologic Basis of Disease,
Seventh Edition. 7th ed. Saunders; 2004.